Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

Cancer Cytopathol. 2019 May;127(5):278-280. doi: 10.1002/cncy.22138. Epub 2019 May 3.

Author

Paul A VanderLaan¹

Affiliation

¹ Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

PMID: 31050221
DOI: 10.1002/cncy.22138

No abstract available

Keywords: ALK; EGFR; NTRK; PD-L1; ROS1; biomarker testing; guideline; immunocytochemistry; immunohistochemistry; non-small cell lung cancer.

Publication types

Editorial
Comment

MeSH terms

B7-H1 Antigen
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung*
Humans
Immunohistochemistry
Lung Neoplasms*

Substances

B7-H1 Antigen
Biomarkers, Tumor